Novonesis AS News - NZM2

Novozymes’ updated financial calendar

Novozymes’ updated financial calendar Please read the full announcement in PDF Attachment 2023_61_Updated_financial_calendar

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European...

Trading by management and close relations of management

Trading by management and close relations of management Please read the full announcement in PDF Attachment 2023_60_Trading_by_managemen...

Update on merger EC offered remedy proposal

Update on merger EC offered remedy proposal Read the full announcement in PDF Attachment Update on merger EC offered remedy proposal

Novozymes launches Quara® LowP for renewable diesel feedstock pre-treatment

Novozymes launches Quara® LowP for renewable diesel feedstock pre-treatment Novozymes, a global leader in biosolutions, marks a significant...

Trading by management and close relations of management

Trading by management and close relations of management Please read the full announcement in PDF Attachment 2023_59_Trading_by_managemen...

Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations

Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations After the first nine months of the 2023 financial...

Interim report for 9M 2023

Interim report for 9M 2023 Please read the full announcement in PDF Attachment 2023_58_Q32023_CompanyAnnouncement

Interim dividend payment

Interim dividend payment Please read the full announcement in PDF Attachment 2023_Interim_dividend

Executive Leadership Team and organizational structure announced for the future combined company of Novozymes and Chr. Hansen

Executive Leadership Team and organizational structure announced for the future combined company of Novozymes and Chr. Hansen Read the full...

Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion

Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion Please read the...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Novonesis AS (NZM2)

Professional-Grade Tools, for Individual Investors.

NZM2 News

Novozymes’ updated financial calendar

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained

Trading by management and close relations of management

Update on merger EC offered remedy proposal

Novozymes launches Quara® LowP for renewable diesel feedstock pre-treatment

Trading by management and close relations of management

Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations

Interim report for 9M 2023

Interim dividend payment

Executive Leadership Team and organizational structure announced for the future combined company of Novozymes and Chr. Hansen

Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion

NZM2 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Novonesis AS (NZM2) News

Novonesis AS (NZM2)

Professional-Grade Tools, for Individual Investors.

NZM2 News

Novozymes’ updated financial calendar

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained

Trading by management and close relations of management

Update on merger EC offered remedy proposal

Novozymes launches Quara® LowP for renewable diesel feedstock pre-treatment

Trading by management and close relations of management

Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations

Interim report for 9M 2023

Interim dividend payment

Executive Leadership Team and organizational structure announced for the future combined company of Novozymes and Chr. Hansen

Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion

NZM2 Discussion

Your Recent History